Release Date: 29/07/11 19:00 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 27.5KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%